5-HPETE

Europe PMC · fetched just now · sorted by publication date

1. 1
   Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies.

   Lu WJ, Ojha R, Rana M, Gautam V, Li JY, Wang SA. · 2026-06-26

   open access unreviewed
2. 2
   In Vitro Anti-Inflammatory Activity of Sour Cherry (Prunus cerasus L.) Seed Oil and Computational Safety Profiling.

   Aydin T, Günbatan T, Berkkan A, Ulutaş OK, Sucu M. · 2026-09-01

   open access unreviewed
3. 3
   Organelle Crosstalk and Metabolic Reprogramming in Idiopathic Pulmonary Fibrosis: Mechanisms and Therapeutic Implications.

   Zhang Y, Teng L, Gong L, Fu Y, Qian M. · 2026-09-01

   open access unreviewed
4. 4
   Lipoxygenase (LOX) signaling in epilepsy: Pathophysiology and therapeutic prospects.

   Rakib MA, Yu Y, Jiang J. · 2026-06-22

   open access unreviewed
5. 5
   Endogenous Lipid Signals in Energy Homeostasis and Fibrosis.

   Di Meo C, Palaniappan S, Urbano C, Cimino G, Cestra F, De Dominicis N, Carnicelli V, Tisi A, Maccarrone M. · 2026-08-11

   open access unreviewed
6. 6
   The Substrate-Engine Model of Ferroptosis: Stage-Specific Targeting of Acyl-CoA Synthetase Long-Chain Family Member 4 and 5‑Lipoxygenase in Alzheimer's Disease.

   Mondal A, Acharya R, Jain S. · 2026-08-04

   unreviewed
7. 7
   Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia-reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics.

   Yu Z, Pei K, Wang X, Li W, Li H, Xie W, Meng X, Zhao T, Ning Y, Liu H, He W. · 2026-05-28

   open access unreviewed
8. 8
   Protocol to purify fatty acid metabolites with two approaches for quantification using liquid chromatography-mass spectrometry.

   Hashidate-Yoshida T, Yamada M, Nagata K, Kihara Y, Kita Y, Shindou H. · 2026-03-22

   cited 1× open access unreviewed
9. 9
   GLIS3, a novel regulator of eicosanoid gene expression and metabolism in normal kidney and polycystic kidney disease.

   Srivastava C, Kang HS, Edin ML, Mukherjee T, Lih FB, Grimm SA, Collier JB, Zeldin DC, Jetten AM. · 2026-02-11

   unreviewed
10. 10
    Next-generation inhibitors of SARS-CoV-2 M<sup>pro</sup> overcome the deficiencies of Paxlovid.

    Luo G, Wang G, Liao C, Zhong B, Fan L, Zhang J, Rao J, Zhang J, Wang Z, Luo M, Yan Y, Lu L, Xu W, Wu F, Gao X… · 2026-04-04

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.